Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. - Wikidata - wikimedia - TriplyDB

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

http://www.wikidata.org/entity/Q34511678

about

Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

http://www.wikidata.org/entity/Q34511678

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@ast

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@en

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@nl

type

label

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@ast

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@en

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@nl

prefLabel

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@ast

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@en

Influenza vaccine immunogenici ...... ral nervous system malignancy.

@nl

P1433

Q34511678-97992FFF-5243-4B49-8A8A-AF1B395B50FD

P1476

Q34511678-A89E17BE-0FDC-40F9-B6F3-8218357493BA

P2093

Q34511678-0E23388C-36EA-45AF-A3C1-7CF40A9B00A4

Q34511678-135501E4-F8D8-4380-B8AE-5F667AAD5856

Q34511678-4EB4902E-AC86-4B28-8581-82AFD3AD596C

Q34511678-5A0DE6BE-D076-4C3F-96BF-65C9FF76E3ED

Q34511678-9277618B-1D5B-462F-A946-01EB8CAD6A15

Q34511678-9E75266E-9969-4137-9F91-6A4012F86F84

Q34511678-A448E826-58B8-4D1D-8E63-224CF94C57DF

Q34511678-EFC024D5-B27B-49E4-BD2D-EEF489751E78

Q34511678-FED577B7-8198-4078-976C-9DE200B430F0

P2860

Q34511678-08B166C5-505A-41B3-8B49-BA635CD91B6F

Q34511678-0DACE218-9FDD-4388-B7CE-FF0AB53F368D

Q34511678-105F4B1E-7B4C-4436-9D12-2D9F2456E64F

Q34511678-116FCEC5-433E-44D3-82E8-662A37388816

Q34511678-15850D44-A8F3-4510-8114-4ADF2F0E24FD

Q34511678-1FD61F81-6218-4BA3-A3DB-245FC53D990A

Q34511678-224F3738-44F2-4F64-857A-2CC047D10DEE

Q34511678-371D84D5-B21D-4C9E-B137-177E59DAA661

Q34511678-385568C3-6ED3-4415-8F03-29D51B3FF085

Q34511678-4B913DB8-08D5-438B-B7D8-BFE7E6C23B37

P304

Q34511678-C437F1E7-E853-4349-97A9-CF316E234DD0

P31

Q34511678-F21735CC-D517-4FBB-9CBE-5F85C7B2EA0F

P356

Q34511678-07E3EBC4-474C-44BB-B8B9-C4C083A41FA7

P433

Q34511678-66B025E6-71CB-48DF-8977-41F5CAD772FA

P478

Q34511678-40C3863E-B7E3-43DD-8769-D95EF5EA8263

P50

Q34511678-8692622F-745E-43EC-A7FA-1821DB97DF45

Q34511678-B20D2B12-B47F-4228-A5AD-6C9640C35371

P577

Q34511678-30003801-18A4-40EA-9143-779686C64D5E

P698

Q34511678-7F0BC39A-C48E-48CB-850A-DAAB6DD30174

P932

Q34511678-0A1BBBD2-A367-4DE9-AF25-EF64EC429648

P356

P1433

P1476

Influenza vaccine immunogenici ...... tral nervous system malignancy

@en

P2093

Annette F Carter

http://www.w3.org/2001/XMLSchema#string

Aurora Pop-Vicas

http://www.w3.org/2001/XMLSchema#string

Glenn J Lesser

http://www.w3.org/2001/XMLSchema#string

Katrina Swett

http://www.w3.org/2001/XMLSchema#string

Kevin High

http://www.w3.org/2001/XMLSchema#string

Maria Blevins

http://www.w3.org/2001/XMLSchema#string

Michael Chan

http://www.w3.org/2001/XMLSchema#string

Michele Harmon

http://www.w3.org/2001/XMLSchema#string

Thomas Ellis

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality associated with influenza and respiratory syncytial virus in the United States

An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paedi

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.

The pandemic H1N1 influenza vaccine results in low rates of seroconversion for patients with hematological malignancies.

A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients.

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

P304

1639-1644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOU051

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Stephen B Tatter

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24714522

http://www.w3.org/2001/XMLSchema#string

P932

4232079

http://www.w3.org/2001/XMLSchema#string